]>
IRCT2016021626581N1 IRCT 2016-04-12 Shiraz University of Medical Sciences The Effect of Nurse-led Care on Stability Time in Therapeutic Range Ischemic Stroke Patients INR: international normalized ratio The Effect of Nurse-led Care on Stability Time in Therapeutic Range of INR in Ischemic Stroke Patients Receiving Warfarin 2013-01-20 anticipated 80 Complete https://irct.ir/trial/21989 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive. N/A ischaemic stroke. Intervention 1: control group: Lab tests for patients Adjusting the dose patients according to clinical protocols that have been developed based on the latest available protocols thrombotic therapy Determine the therapeutic range of INR. Intervention 2: Intervention group: Lab tests for patients The necessary training related to using warfarin correctly To familiarize the patients with risk factors for recurrent stroke and bleeding and help in controlling them Adjusting the warfarin dose according to clinical protocols that have been developed based on the latest available protocols of thrombotic therapy educating the importance of treatment follow-up Determine the therapeutic range of INR.
public Mrs. M. kargar (Executive)
Nursing and midwifery School
Shiraz Iran (Islamic Republic of) +98 71 3647 4254 kargarm@sums.ac.ir Shiraz University of Medical Sciences scientific M. kargar
Nursing and midwifery School
Shiraz Iran (Islamic Republic of) +98 71 3647 4254 kargarm@sums.ac.ir Shiraz University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Patients with ischemic stroke have been one reason; Patients whose disease is confirmed by a neurologist doctor and refer to warfarin clinics in Specified time range of in the study; Patients under 76 years are allowed to enter the study; Patients who live in shiraz or around the city of Shiraz and refer to clinic in the established days; Patients who are committed to the principles of the laboratory tests are required to use the unit for lab test checking; Patients willing to participate in the study and signed an informed consent form 7 Patients taking warfarin for one month before starting the study Exclusion criteria: Patients who have to be discontinued warfarin for any reason; Deaths during the study period due to complications from a stroke or other causes; Patients did not provide the necessary cooperation to control their INR during the study period 20 years 75 years Both G 45 ,G 46 Transient cerebral ischaemic attacks and related syndromes ,Vascular syndromes of brain in cerebrovascular diseases Other Other control group: Lab tests for patients Adjusting the dose patients according to clinical protocols that have been developed based on the latest available protocols thrombotic therapy Determine the therapeutic range of INR Intervention group: Lab tests for patients The necessary training related to using warfarin correctly To familiarize the patients with risk factors for recurrent stroke and bleeding and help in controlling them Adjusting the warfarin dose according to clinical protocols that have been developed based on the latest available protocols of thrombotic therapy educating the importance of treatment follow-up Determine the therapeutic range of INR INR. Timepoint: Baseline and then at intervals required. Method of measurement: blood test. Recurrent stroke and bleeding. Timepoint: At each visit of patients. Method of measurement: question and observation. Shiraz University of Medical Sciences Approved 2012-12-24 Shiraz University of Medical Sciences Research center, floor 7, Central Building University of Medical Sciences,Next to the Red Crescent, zand st Shiraz Iran (Islamic Republic of)